Document oeYB1X3d3o57R6ao2kjV1D6BX

Message From: Sent: To: Subject: Gross, Mackenzie A. EOP/WHO Ex. 6 Personal Privacy (PP) 6/29/2018 8:41:03 PM Santerre, Charlie R. EOP/OSTP [j____ _______________________ j Kratsios, Michael J. EOP/OSTP [[ Ex/"6"Per"so"naiPrivacy(PPj" 1; Cunliffe, Laura M. EOP/WHO fi x Z6 Perso ria Privacy (PP )P ; Talento, Kathryn F. EOP/WHO G x. 6 Personal Privacy (PP) r]; Slater, Abigail A. EP/WH'___J 'Abram, Anna1[nna."bram@fda.hhs.gov]; stroff, Stephen [Stephen.Ostroff@fda.hhs.gov]; 'Nalubola, Ritu1 [Ritu.Nalubola@fda.hhs.gov]; Klippenstein, Brian - OSEC, Washington, DC [Brian.Klippenstein@osec.usda.gov]; 'Adcock, Rebeckah - OSEC, Washington, DC [Rebeckah.Adcock@osec.usda.gov]; 'Chou, Fan-Li - ARS' [FanLi.Chou@ARS.USDA.GOV]; 'Hoskins, Dudley - OSEC, Washington, DC [Dudley.Hoskins@osec.usda.gov]; Beck, Nancy [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=168ecb5184ac44de95a913297f353745-Beck, Nancy]; Mendelsohn, Mike [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=720bl6elb31742738a728d8d2814beef-Mendelsohn, Mike] Ag Biotech follow-up Hi team, thanks for another great biotech discussion today! For next steps, we're asking that each Agency lay out what steps they can take to facilitate the review of any priority products. There were a lot of ideas that sounded like they fit the bill mentioned in today's meeting (such as using the IR4 program or enhancing customer service as developers put their data packages togetehr) and I think it would be helpful to flesh out those ideas somewhat. Please get me an outline for what you think your Agency can do in this space by COB Monday, July 9. We'll then have a follow up meeting to discuss further. Thanks and I hope everyone has a great weekend! Mackenzie Sierra Club v. EPA 18cv3472 NDCA Tier 12 ED 002061E 00001316-00001